COMPANY

Nested Therapeutics

HQ: Cambridge, MA source · nestedtx.com ↗

Nested Therapeutics Inc. (herein referred to as the “Nested,” “we,” “us” or “our”) provides and makes available this web site located at www.nestedtx.com (the “Web Site”). From company website Source · Oct 13, 2026

Keywords: Oncology MEK Mutation RAF Gene Mutation Ras (KRAS or NRAS) Gene Mutation Melanoma NSCLC Glioma MAPK Pathway Gene Mutation NST-628

Location: Cambridge, MA · source · Oct 14, 2026

Profile checked Oct 10, 2026

1Trials (company is sponsor)

Timeline

Apr 9, 2024 Trial start Phase 1: A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors source ↗

Upcoming milestones

2028-11 (ESTIMATED) · Phase 1 · A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors · NCT06326411

Estimated primary completion per ClinicalTrials.gov. Dates move.

Clinical trials (lead sponsor) 1

Record	Title	Phase	Status	Start	Primary completion
NCT06326411	A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors	Phase 1	Recruiting	Apr 9, 2024	2028-11 (estimated)